J2010 HCPCS code: Injection, lincomycin hcl, up to 300 mg
J2010 is the HCPCS Level II code for injection, lincomycin hcl, up to 300 mg. In 2024 Medicare paid an average of $6.57 per service for J2010 across 24,392 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 10 per day on outpatient hospital claims. Medicare volume fell 14% from 2022 to 2024 (28,490 to 24,392 services). In 2024, about 1,271 clinicians billed Medicare for J2010 for 11,328 beneficiaries; Mississippi, Texas, Louisiana accounted for 55% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1982-01-01 |
| Last action effective | 1997-01-01 |
Who bills J2010 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,271 |
| Medicare beneficiaries | 11,328 |
| States with claims | 28 |
| Share of services in top 3 states (Mississippi, Texas, Louisiana) | 55% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2010, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 28,490 | 13,500 | $9.47 | $6.57 |
| 2023 | 26,271 | 12,400 | $9.87 | $6.90 |
| 2024 | 24,392 | 11,328 | $9.53 | $6.57 |
States with the most J2010 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Mississippi | 5,949 | $6.54 |
| Texas | 4,420 | $6.25 |
| Louisiana | 2,978 | $6.68 |
| Tennessee | 2,377 | $6.89 |
| Alabama | 1,599 | $6.40 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 10 | Clinical: Data |
| practitioner claims | 10 | Clinical: Data |
What changed for J2010
- 1982-01-01: J2010 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2010?
J2010 is the HCPCS Level II code for injection, lincomycin hcl, up to 300 mg. Short descriptor: "Lincomycin injection".
How much does Medicare pay for J2010?
In 2024, the average Medicare payment was $6.57 per service (average allowed $9.53).
Does Medicare cover J2010?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J2010 can be billed per day?
10 on outpatient hospital claims; 10 on practitioner claims (NCCI medically unlikely edits).
Related J20 codes
- J2001 — Injection, lidocaine hcl for intravenous infusion, 10 mg
- J2002 — Injection, lidocaine hcl in 5% dextrose, 1 mg
- J2003 — Injection, lidocaine hydrochloride, 1 mg
- J2004 — Injection, lidocaine hcl with epinephrine, 1 mg
- J2020 — Injection, linezolid, 200 mg
- J2021 — Injection, linezolid (hospira), not therapeutically equivalent to j2020, 200 mg
- J2060 — Injection, lorazepam, 2 mg
- J2062 — Loxapine for inhalation, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2010
- Watch J2010 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2010
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.